Chemists from Scripps Research and the University of California, Los Angeles, have developed methods for the precise, flexible modification of a broad class of chemical compounds called bicyclic ...
The inhibition of pathological protein-protein interactions is a promising approach for treating a large number of diseases, including many forms of cancer. A team of researchers has now developed a ...
BERLIN & CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bayer and Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics by utilizing ...
Sequential intravesical gemcitabine and docetaxel versus bacillus Calmette-Guérin for the treatment of high-risk, treatment-naïve, non-muscle invasive bladder cancer. This is an ASCO Meeting Abstract ...
A new techniques enable unprecedented versatility in the design of drug molecules. Chemists from Scripps Research and the University of California, Los Angeles, have developed methods for the precise, ...
With its simple bicyclic skeleton, 2-quinuclidone doesn't look like it would be much of a challenge to make. But thanks to an unusually labile amide linkage, this modest lactam has eluded synthetic ...
Bicyclic peptides have spurred some multimillion-dollar deals in recent years, as drug developers begin to exploit the peptides’ power to target and bind proteins. Now, researchers led by Christoph ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results